Company / R&D per Share
Solventum R&D per Share History
FY2022-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$4.39
FY2023
5-year range
$4.39 / $4.44
FY2022-FY2023
Trend
-1.2%
vs FY2022
Sector context
#10 of 108
Health Care
What the data says
Among 108 Health Care companies, Solventum is in the top 9% for r&d per share.
Based on SEC 10-K filings.
4.39 in FY2023. Top quartile in the Health Care sector.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 108This company $4.39 Sector average $2.07
▼
+112.0% above sector average
Key checks
Key Insights
- In FY2023, r&d per share decreased 1.2% year-over-year.
- Ranks #10 out of 108 companies in the Health Care sector.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
- Strong return on equity: 30.6%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $4.39 | -1.2% |
| FY2022 | $4.44 | - |
As of FY2023 · SEC 10-K · Updated Feb 28, 2026